25 Aug 2023
According to a study published in the Journal of Diabetes Complications, semaglutide is more effective in helping manage type 2 diabetes than other GLP-1 receptor agonists, including greater reductions in HbA1C, body weight, waist circumference and cardiometabolic improvements.
Healio
Study links premature ovarian insufficiency (POI) to risk of mortality
17 May 2024
Cardiovascular disease mortality associated with low testosterone in men
17 May 2024
People with obesity using semaglutide see cardiovascular improvements
17 May 2024
Men with obesity lose more weight with cash incentives, research says
17 May 2024
Research Assistant in Endocrinology (University of Sheffield)
14 May 2024